Skip to main content

Advances in Nanomedicine for Cancer Therapy

Edited by:

Christophe Nicot, PhD, Kansas University Medical Center, United States of America

Submission Status: Open   |   Submission Deadline: 30 June 2025


Molecular Cancer is calling for submissions to our Collection on 'Advances in Nanomedicine for Cancer Therapy.' This Collection aims to explore innovative research and breakthrough developments in the application of nanotechnology for cancer diagnosis, treatment, and management.

About the Collection

Molecular Cancer is calling for submissions to our Collection on 'Advances in Nanomedicine for Cancer Therapy'. This Collection aims to explore innovative research and breakthrough developments in the application of nanotechnology for cancer diagnosis, treatment, and management. 

Topics of interest include, but are not limited to, nanoparticle-based drug delivery systems, targeted therapy, nanomaterials for imaging and early detection, immunotherapy, and personalized medicine approaches. We seek contributions that highlight novel methodologies, clinical trials, and interdisciplinary research that push the boundaries of current cancer therapies.


Image credit: © Chaudary / Generated with AI / Stock.adobe.com

  1. As promising noninvasive biomarkers, nucleic acids provide great potential to innovate cancer early detection methods and promote subsequent diagnosis to improve the survival rates of patient. Accurate, straig...

    Authors: Weipan Peng, Mengting Shi, Bin Hu, Jingyu Jia, Xinyue Li, Nan Wang, Shuli Man, Shengying Ye and Long Ma
    Citation: Molecular Cancer 2025 24:78
    Content type: Review Published on:

  2. Abnormal lipid metabolism plays an important role in the development and progression of almost all cancer types, especially hepatocellular carcinoma (HCC) as the liver is the central organ for lipid storage an...

    Authors: Linzhuo Huang, Rui Xu, Siyu Chen, Chunhao Lin, Wende Li, Senlin Li, Phei Er Saw, Lei Zhang and Xiaoding Xu
    Citation: Molecular Cancer 2025 24:73
    Content type: Research Published on:

  3. Clinical cancer treatment modalities include radiation as one of the first-line therapies used for treating almost two-thirds of cancer patients. Combinational therapy for cancer is becoming extremely popular,...

    Authors: Tejaswini Appidi, Debarghya China, George-Răzvan Ștefan, Michele Moreau, Serena Mao, Esteban Velarde, Ngeh Toyang, Henry Lowe, Aravind Kumar Rengan, Kai Ding and Wilfred Ngwa
    Citation: Molecular Cancer 2025 24:68
    Content type: Research Published on:

  5. The activity of neurons in the vicinity of tumors is linked to a spectrum of cellular mechanisms, including the facilitation of tumor cell proliferation, synapse formation, angiogenesis, and macrophage polariz...

    Authors: Yu Zhang, Qili Liao, Xuyang Wen, Jiayan Fan, Tifei Yuan, Xuemei Tong, Renbing Jia, Peiwei Chai and Xianqun Fan
    Citation: Molecular Cancer 2025 24:44
    Content type: Review Published on:

  6. The diagnosis and treatment of non-small cell lung cancer in clinical settings face serious challenges, particularly due to the lack of integration between the two processes, which limit real-time adjustments ...

    Authors: Chong Qiu, Fei Xia, Qingchao Tu, Huan Tang, Yinan Liu, Hongda Liu, Chen Wang, HaiLu Yao, Linying Zhong, Yuanfeng Fu, Pengbo Guo, Weiqi Chen, Xinyu Zhou, Li Zou, Licheng Gan, Jiawei Yan…
    Citation: Molecular Cancer 2025 24:43
    Content type: Research Published on:

  7. Rectal cancer accounts for over 35% of the worldwide colorectal cancer burden representing a distinctive subset of cancers from those arising in the colon. Colorectal cancers exhibit a continuum of traits that...

    Authors: Diogo Coelho, Diogo Estêvão, Maria José Oliveira and Bruno Sarmento
    Citation: Molecular Cancer 2025 24:35
    Content type: Review Published on:

  9. Metastasis is a leading cause of cancer-related death in castration-resistant prostate cancer (CRPC) patients. Circular RNAs (circRNAs) have emerged as key regulators of the metastasis of various cancers. Howe...

    Authors: Xiang Pan, Kailai Chen, Wei Gao, Meiqi Xu, Fanlong Meng, Mengyuan Wu, Zi Qi Wang, Yun Qi Li, Wanhai Xu, Manjie Zhang and Yakun Luo
    Citation: Molecular Cancer 2025 24:29
    Content type: Research Published on:

  13. Lipid nanoparticles (LNPs) for mRNA delivery have advanced significantly, but LNP-mediated DNA delivery still faces clinical challenges. This study compared various LNP formulations for delivering DNA-encoded ...

    Authors: Dafei Chai, Junhao Wang, Jing Ming Lim, Xiaohui Xie, Xinfang Yu, Dan Zhao, Perry Ayn Mayson Maza, Yifei Wang, Dana Cyril-Remirez, Ken H. Young and Yong Li
    Citation: Molecular Cancer 2025 24:12
    Content type: Research Published on:

  14. cGAS-STING pathway stands at the forefront of innate immunity and plays a critical role in regulating adaptive immune responses, making it as a key orchestrator of anti-tumor immunity. Despite the great potent...

    Authors: Xiaohong Ying, Qiaohui Chen, Yongqi Yang, Ziyu Wu, Wan Zeng, Chenxi Miao, Qiong Huang and Kelong Ai
    Citation: Molecular Cancer 2024 23:277
    Content type: Review Published on:

  15. Malignant bone tumors, which are difficult to treat with current clinical strategies, originate from bone tissues and can be classified into primary and secondary types. Due to the specificity of the bone micr...

    Authors: Yujing Guan, Wei Zhang, Yuling Mao and Shenglong Li
    Citation: Molecular Cancer 2024 23:246
    Content type: Review Published on:

  16. Normal tissue and immune organ protection are critical parts of the tumor radiation therapy process. Radiation-induced immune organ damage (RIOD) causes several side reactions by increasing oxidative stress an...

    Authors: Shigao Huang, Min Xu, Xiaojun Deng, Qingyue Da, Miaomiao Li, Hao Huang, Lina Zhao, Linlin Jing and Haibo Wang
    Citation: Molecular Cancer 2024 23:234
    Content type: Research Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of Research Articles and Reviews. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. 

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Advances in Nanomedicine for Cancer Therapy" under the “Details” tab during the submission stage. Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editor has no competing interests with the submissions which are handled through the peer-review process. The peer-review of any submissions for which the Editor has competing interests is handled by another Editorial Board Member who has no competing interests.